Ryan D. Morrison

2.3k total citations
73 papers, 1.6k citations indexed

About

Ryan D. Morrison is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ryan D. Morrison has authored 73 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Ryan D. Morrison's work include Neuroscience and Neuropharmacology Research (38 papers), Receptor Mechanisms and Signaling (30 papers) and Pharmacological Receptor Mechanisms and Effects (13 papers). Ryan D. Morrison is often cited by papers focused on Neuroscience and Neuropharmacology Research (38 papers), Receptor Mechanisms and Signaling (30 papers) and Pharmacological Receptor Mechanisms and Effects (13 papers). Ryan D. Morrison collaborates with scholars based in United States, United Kingdom and Russia. Ryan D. Morrison's co-authors include J. Scott Daniels, Craig W. Lindsley, Colleen M. Niswender, P. Jeffrey Conn, Carrie K. Jones, Anna L. Blobaum, Frank W. Byers, Thomas M. Bridges, C. David Weaver and Kyle A. Emmitte and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ryan D. Morrison

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan D. Morrison United States	25	1.0k	900	185	132	93	73	1.6k
Juan Zhen United States	22	1.0k 1.0×	865 1.0×	141 0.8×	44 0.3×	116 1.2×	55	1.8k
Alessandro Bonifazi United States	23	979 1.0×	797 0.9×	193 1.0×	74 0.6×	115 1.2×	68	1.4k
Cen Xu United States	22	615 0.6×	775 0.9×	263 1.4×	98 0.7×	157 1.7×	52	1.9k
Alessandro Piergentili Italy	25	864 0.9×	535 0.6×	476 2.6×	44 0.3×	112 1.2×	93	1.5k
H. Donald Burns United States	23	497 0.5×	554 0.6×	102 0.6×	84 0.6×	125 1.3×	58	1.3k
Pierre Mallorga United States	19	855 0.8×	932 1.0×	164 0.9×	129 1.0×	108 1.2×	43	1.6k
Rikki N. Waterhouse United States	20	872 0.9×	617 0.7×	159 0.9×	35 0.3×	143 1.5×	46	1.4k
Ethan S. Burstein United States	32	1.9k 1.9×	1.3k 1.4×	135 0.7×	94 0.7×	258 2.8×	91	3.1k
Dianne Kowal United States	21	713 0.7×	466 0.5×	347 1.9×	71 0.5×	287 3.1×	39	1.3k
Sarah Grimwood United States	28	1.1k 1.1×	1.0k 1.1×	401 2.2×	123 0.9×	194 2.1×	52	2.0k

Countries citing papers authored by Ryan D. Morrison

Since Specialization

Citations

This map shows the geographic impact of Ryan D. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan D. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan D. Morrison more than expected).

Fields of papers citing papers by Ryan D. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan D. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan D. Morrison. The network helps show where Ryan D. Morrison may publish in the future.

Co-authorship network of co-authors of Ryan D. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan D. Morrison. A scholar is included among the top collaborators of Ryan D. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan D. Morrison. Ryan D. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaule, Patricia, Charles T. Robbins, Salisha Hill, et al.. (2025). 127 Analytical Validation and Prospective Study of a High-Sensitivity HER2 (HS-HER2) Quantitative Immunofluorescence Assay for Enhanced Stratification of HER2-Low Breast Cancer Patients. Laboratory Investigation. 105(3). 102351–102351.

Gruver, Aaron M., Bradley L. Ackermann, Ryan D. Morrison, et al.. (2021). Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity. Journal of Clinical Pathology. 75(9). 636–642. 5 indexed citations

Liebler, D.C., Ryan D. Morrison, Robbert J.C. Slebos, et al.. (2020). Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry. Laboratory Investigation. 100(6). 874–886. 22 indexed citations

Liebler, D.C., Timothy R. Holzer, Ryan D. Morrison, et al.. (2020). Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer. Scientific Reports. 10(1). 9805–9805. 19 indexed citations

Han, Jin H., Alex Chen, Eduard E. Vasilevskis, et al.. (2019). Supratherapeutic Psychotropic Drug Levels in the Emergency Department and Their Association with Delirium Duration: A Preliminary Study. Journal of the American Geriatrics Society. 67(11). 2387–2392. 3 indexed citations

Lindenfeld, JoAnn, et al.. (2018). 40EMF Outpatient Lisinopril and Losartan Blood Levels Are Associated With In-Hospital Acute Kidney Injury Among Patients With Acute Heart Failure. Annals of Emergency Medicine. 72(4). S19–S19.

Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2018). Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5. Bioorganic & Medicinal Chemistry Letters. 29(1). 47–50. 4 indexed citations

Fuller, John C., Lisa M. Pitchford, Ryan D. Morrison, et al.. (2018). In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate. Food and Chemical Toxicology. 121. 541–548. 15 indexed citations

Sutherland, Jeffrey J., Ryan D. Morrison, J. Scott Daniels, Stephen Milne, & Timothy P. Ryan. (2017). Managing Psychotropic Medications in Complex, Real-World Patients Using Comprehensive Therapeutic Drug Monitoring. ACS Chemical Neuroscience. 8(8). 1641–1644. 7 indexed citations

10.

Sutherland, Jeffrey J., Thomas M. Daly, Karen Jacobs, et al.. (2017). Medication Exposure in Highly Adherent Psychiatry Patients. ACS Chemical Neuroscience. 9(3). 555–562. 5 indexed citations

11.

Gogliotti, Rocco D., Changho Han, Charles W. Locuson, et al.. (2015). Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility. Bioorganic & Medicinal Chemistry Letters. 25(13). 2720–2725. 11 indexed citations

12.

Ghoshal, Ayan, Jerri M. Rook, Jonathan W. Dickerson, et al.. (2015). Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Neuropsychopharmacology. 41(2). 598–610. 81 indexed citations

13.

Gentry, Patrick R., Masaya Kokubo, Thomas M. Bridges, et al.. (2014). Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M₅‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe. ChemMedChem. 9(8). 1677–1682. 21 indexed citations

14.

Felts, Andrew S., Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety. Bioorganic & Medicinal Chemistry Letters. 23(21). 5779–5785. 27 indexed citations

15.

Manka, Jason, Alice L. Rodriguez, Ryan D. Morrison, et al.. (2013). Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1. Bioorganic & Medicinal Chemistry Letters. 23(18). 5091–5096. 9 indexed citations

16.

Felts, Andrew S., Alice L. Rodriguez, Daryl F. Venable, et al.. (2013). Substituted 1-Phenyl-3-(pyridin-2-yl)urea Negative Allosteric Modulators of mGlu₅: Discovery of a New Tool Compound VU0463841 with Activity in Rat Models of Cocaine Addiction. ACS Chemical Neuroscience. 4(8). 1217–1228. 14 indexed citations

17.

Lovell, Kimberly M., Andrew S. Felts, Alice L. Rodriguez, et al.. (2013). N-Acyl-N′-arylpiperazines as negative allosteric modulators of mGlu1: Identification of VU0469650, a potent and selective tool compound with CNS exposure in rats. Bioorganic & Medicinal Chemistry Letters. 23(13). 3713–3718. 13 indexed citations

18.

Wenthur, Cody J., Ryan D. Morrison, Andrew S. Felts, et al.. (2013). Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu₃ Selective and CNS Penetrant Negative Allosteric Modulator (NAM). Journal of Medicinal Chemistry. 56(12). 5208–5212. 47 indexed citations

19.

Jones, Carrie K., Michael Bubser, Analisa D. Thompson, et al.. (2011). The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 340(2). 404–421. 81 indexed citations

20.

Melancon, Bruce J., Thomas M. Bridges, Gary A. Sulikowski, et al.. (2011). Development of a more highly selective M1 antagonist from the continued optimization of the MLPCN Probe ML012. Bioorganic & Medicinal Chemistry Letters. 22(2). 1044–1048. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact